Search

25 Feb 2013: Psychogenic diseases, formerly known as ‘hysterical’ illnesses, can have many severe symptoms such as painful cramps or paralysis but without any physical

17 Mar 2011: The fact that drugs can produce mind-altering effects through chemical activity has been known for centuries,” explained Professor Robbins, who is Director of the Behavioural and Clinical Neuroscience Institute and

21 Jan 2019: A team from the Behavioural and Clinical Neuroscience Institute at the University of Cambridge has developed and tested ‘Decoder’, a new game that is aimed at helping users improve their attention

18 May 2023: Professor James Rowe FMedSci. Professor of Cognitive Neurology, Department of Clinical Neurosciences, and MRC Cognition and Brain Sciences Unit. ... His work integrates cognitive neuroscience, brain imaging, fluidic biomarkers, computational models and

16 Feb 2015: The Cambridge Drug Discovery Institute will be located on the Cambridge Biomedical Campus, the centrepiece of the largest biotech cluster outside the United States, and involves many members of Cambridge Neuroscience, ... We’re providing the investment

28 Sep 2010: Molly Crockett. The new research, by scientists at the University of Cambridge's Behavioural and Clinical Neuroscience Institute, discovered that healthy volunteers given drugs which increase their serotonin, selective serotonin reuptake ... Ms Molly

4 Jan 2011: Professor Barry Everitt and Dr Jonathan Lee of the MRC-Wellcome Behaviour and Clinical Neuroscience Institute have shown that they can selectively impair memories associated with drug addiction and PTSD by

23 May 2013: A new book co-authored by Professor Barbara Sahakian explores ‘hot’ and ‘cold’ decision-making and the possible improvement of bad or risky decisions with

6 May 2011: The Twitter Brain Team. Conception: Dr. Hannah Critchlow, Cambridge Neuroscience Strategic Manager, working with Mr Nick Saffell, University Communications Office. ... Presenter: Professor Ed Bullmore, Department of Psychiatry, Brain Mapping Unit,

24 Apr 2012: Dr Karen Ersche, of the Behavioural and Clinical Neuroscience Institute (BCNI) at the University of Cambridge. ... Dr Karen Ersche, of the Behavioural and Clinical Neuroscience Institute (BCNI) at the University of Cambridge, said: “As we age, we all

1 Dec 2009: The programme, which is led by Professor Peter St George-Hyslop in the Cambridge Institute of Medical Research and Department of Clinical Neurosciences, is a major collaborative effort involving 15 scientists ... interests that range from theory to

1 May 2015: He might be suffering with clinical depression, say the authors, and certainly describes key symptoms of low self-confidence and low mood: “The world don’t need you…I know depression

17 Nov 2015: The research was primarily supported by the University of Cambridge Behavioural and Clinical Neuroscience Institute, funded by a joint award from the UK Medical Research Council and the Wellcome Trust.

11 Mar 2010: The study by researchers at the Western Psychiatric Institute and Clinic at the University of Pittsburgh, and The MRC/Wellcome Trust Behavioural and Clinical Neuroscience Institute at the University of Cambridge

21 Jun 2011: Dr Ersche, of the Behavioural and Clinical Neuroscience Institute (BCNI) at the University of Cambridge, said: “This research gives us important insight into why some people are more vulnerable to drug ... The study was funded and sponsored by

20 Mar 2009: The Parliamentary Office of Science and Technology (POST) report, entitled 'Delaying Gratification', was written by Laura Haynes, a University of Cambridge PhD candidate in Behavioural Economics at the Behavioural and Clinical ... Neuroscience Institute,

15 Sep 2011: Dr Molly Crockett, co-first author who worked on the research while a PhD student at the University of Cambridge’s Behavioural and Clinical Neuroscience Institute (and currently based at the ... Dr Molly Crockett, co-first author who worked on the

15 Nov 2018: Read more here.

12 Nov 2008: Professor Barbara Sahakian, lead author of the study which was carried out at the Behavioural and Clinical Neuroscience Institute, said: "This study has shown that not all risk-taking is disadvantageous,

2 Jun 2016: Our behaviour is shaped by many pathways. Geert de Vries, director of the Neuroscience Institute at Georgia State University, has another take on sex differences in the brain. ... Since 1993, the inclusion of women has been a requirement in clinical

6 Oct 2011: Treatment for stimulant dependence is difficult and often individuals battling addiction relapse several times,” said Dr Karen Ersche, of the Behavioural and Clinical Neuroscience Institute (BCNI) at the University of Cambridge, ... The study was

20 Mar 2013: added. Under the supervision of Dr Claire Baker in the Department of Physiology, Development and Neuroscience, Connie is trying to understand how OECs are made and how they function in the

31 Aug 2012: Dr Karen Ersche, of the Behavioural and Clinical Neuroscience Institute (BCNI) at the University of Cambridge. ... Dr Ersche, of the Behavioural and Clinical Neuroscience Institute (BCNI) at the University of Cambridge, said: “It has long been known

2 Jul 2015: Professor Joe Herbert, a co-author of this study from the Department of Clinical Neurosciences at the University of Cambridge, reported in an earlier field study that traders made significantly higher ... School of Clinical Medicine.

26 Oct 2010: Professor Paul Fletcher, the Department of Psychiatry and the Behavioural & Clinical Neuroscience Institute. ... Their findings are reported today in The Journal of Neuroscience. Professor Paul Fletcher, from the Department of Psychiatry and the

21 Feb 2017: This work was funded by the Medical Research Council and was conducted at the NIHR Cambridge Biomedical Research Centre and the Behavioural and Clinical Neuroscience Institute.

3 Feb 2012: Dr Karen Ersche, of the Behavioural and Clinical Neuroscience Institute (BCNI) at the University of Cambridge. ... Dr Karen Ersche, of the Behavioural and Clinical Neuroscience Institute (BCNI) at the University of Cambridge, said: “It has long been

18 Jul 2014: not stop their medication on the basis of this research, ” adds Dr Graham Murray from the Behavioural and Clinical Neuroscience Institute and the Department of Psychiatry at University of Cambridge.

16 Jun 2016: habits. The work was funded by the Medical Research Council and was conducted at the NIHR Cambridge Biomedical Research Centre and the Behavioural and Clinical Neuroscience Institute.

11 Aug 2011: This has important implications for future treatment strategies. Alastair Compston, Professor of Neurology and Head of the Department of Clinical Neurosciences at the University of Cambridge, and co-founder of the

11 May 2015: The Fellows elected from the University of Cambridge are:. Professor Roger Barker – Professor of Clinical Neuroscience and Honorary Consultant Neurologist, Addenbrooke’s Hospital and Department of Clinical Neurosciences. ... Professor Sarah Bray –

1 May 2010: Professor Paul Fletcher, the Bernard Wolfe Professor of Health Neuroscience in the Department of Psychiatry, is investigating the ways in which we form beliefs about our environment, and how we use ... Research described here takes place within the

12 Jul 2011: Siblings of people with autism show a similar pattern of brain activity to that seen in people with autism when looking at emotional facial expressions. The

27 May 2009: Dr Peter Smielewski. Over the past decade, Dr Peter Smielewski and Dr Marek Czosnyka in the Neurosurgery Unit of the Department of Clinical Neurosciences have been developing software as an aid

6 Mar 2017: In this study, researchers at Cambridge’s Behavioural and Clinical Neuroscience Institute tested 43 OCD patients and 35 matched healthy volunteers to see how well those people with OCD were able

4 Jan 2011: Modern medicine and the science of public health have improved the lot of the Common Man and his life expectancy is gradually increasing. While this is to be

15 Dec 2020: It is linked to functional decline, decreased quality of life, loss of independence and poorer survival,” said Maura Malpetti, a cognitive scientist at the Department of Clinical Neurosciences, University of Cambridge. ... Here we show its importance

20 Jun 2017: become a medicine – drug discovery, formulation, toxicology, clinical trial design, regulators, business models.”. ... For Professor Randall Johnson, Apollo funds have meant that his research in Cambridge’s Department of Physiology, Development and

17 Mar 2022: users. However, since the overall number of patients receiving lithium was small and this was an observational study, larger clinical trials would be needed to establish lithium as a potential treatment ... Further experimental medicine and clinical

24 Apr 2012: Together, we are putting together resources and scientific interest to really develop stem cells and their clinical application. ... It will take time for us to assess this clinical use and show that it is safe as well as effective,” he explained,

21 Oct 2011: Veterinary Medicine, whose work on multiple sclerosis is about to move into clinical trials (see below). ... An effective treatment for halting the destruction of oligodendrocytes, alemtuzumab (Campath), was developed in Cambridge by Professor Alastair

21 Feb 2019: The Principal Investigator for RESCUE-RACER is Professor Peter Hutchinson from Cambridge’s Department of Clinical Neurosciences, and a neurosurgeon at Cambridge University Hospitals NHS Foundation Trust. ... Dr Deakin is a PhD student at Robinson

23 Jan 2023: To date, most studies of SSRIs have only examined their short term use, but, for clinical use in depression these drugs are taken chronically, over a longer period of time.

8 Feb 2012: Almost 100% of people with Down’s Syndrome develop pathological signs of Alzheimer’s, and clinical symptoms are seen in Down’s Syndrome around 40 years earlier than in the general ... clinical symptoms are seen in DS around 40 years earlier than in

7 Jun 2010: The results are published today in the Archives of General Psychiatry and the research was funded by GlaxoSmithKline and conducted within the GlaxoSmithKline Clinical Unit Cambridge and the Behavioural and Clinical ... Neuroscience Institute (BCNI).

19 Sep 2017: This study was conducted at the University of Cambridge’s Behavioural and Clinical Neuroscience Institute, funded by Medical Research Council and Wellcome Trust.

8 Mar 2017: Around one in 20 teenagers suffers from depression. Episodes can last for several months. Unfortunately, about 50% of teenagers who have a depressive episode

21 Oct 2011: Who donates his or her brain to science? Where do these brains go and how are they used? These are just some of the questions a new exhibition, inspired by the

23 Oct 2018: YBOCS scores are the most widely used clinical assessments for assessing the severity of OCD. ... The culture—like no other—embraces novel ideas, even if outlandish and far-fetched on the surface,” says Baland Jalal, a neuroscientist at

21 Sep 2016: Understandably, most of the researchers tackling Alzheimer’s approach the disease as a clinical – or at least a biological – problem. ... These could then be taken up by pharmaceutical companies for clinical trials, removing some of the risk that